10q10k10q10k.net
TriSalus Life Sciences, Inc.

TriSalus Life Sciences, Inc.TLSIEarnings & Financial Report

Nasdaq · Health Care · Surgical & Medical Instruments & Apparatus

TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.

Top Holders

Holder% OwnedSharesChangeAs of
MedTech Acquisition Sponsor LLC84.50%
6.3M
—2023-07-06
Frankenius Equity AB24.10%
6.4M
—2023-08-21
Mats Wahlstr m10.40%
2.7M
—2023-08-21
David J. Matlin8.20%
2.3M
—2023-08-21
James J. Pallotta6.24%
1.9M
—2024-12-04
Unique Diamond Investments Limited5.90%
1.5M
—2023-08-29
Christopher Dewey5.60%
1.5M
—2023-08-21
Michael P. Stansky5.30%
1.4M
—2023-08-22
Gene R. McGrevin5.30%
1.4M
—2023-08-21
Magnetar Financial LLC4.20%
1.2M
▼ -3.80pp2023-08-14

Insider Transactions

Net 90d: +$1.65M · buys $1.79M / sells $134.4K
Range:
Action:
Role:
InsiderRoleAction
2026-03-17Szela Mary TCEO and PresidentSell (open market)
15.9K
$3.85$61.4K
2026-03-16Jodi DevlinChief of Clinical OperationsSell (open market)
273
$4.12$1.1K
2026-03-16Richard MarshakChief Commercial OfficerSell (open market)
419
$4.12$1.7K
2026-03-16Cox Bryan F.Chief of ResearchSell (open market)
579
$4.12$2.4K
2026-03-16Jennifer StevensChief Regulatory OfficerSell (open market)
774
$4.12$3.2K
2026-03-12Jodi DevlinChief of Clinical OperationsSell (open market)
1.8K
$4.09$7.2K
2026-03-12Richard MarshakChief Commercial OfficerSell (open market)
1.6K
$4.09$6.5K
2026-03-12Cox Bryan F.Chief of ResearchSell (open market)
1.5K
$4.09$6.0K
2026-03-12Jennifer StevensChief Regulatory OfficerSell (open market)
1.6K
$4.09$6.3K
2026-03-11Jodi DevlinChief of Clinical OperationsSell (open market)
1.2K
$4.13$4.8K
1–10 of 20
Page 1 / 2